Jul 16, 2025 | Legal Compliance, News, State-Specific Regulations
Colorado’s House Bill 25-1024 (HB25-1024), signed into law on April 7, 2025, adds critical obligations for medical professionals who delegate medical-aesthetic procedures to unlicensed staff. If you’re a Colorado physician or advanced practice registered nurse...
Jul 15, 2025 | Legal Compliance, News
Semaglutide, the active ingredient in Ozempic and Wegovy, is set to lose patent protection in China on March 20, 2026. This is years ahead of its expiration in the United States, Europe and Japan. As that date approaches, Chinese pharmaceutical companies (as well as...
Jul 9, 2025 | Legal Compliance, Starting a Business, State-Specific Regulations
With IV hydration therapy clinics rapidly gaining popularity across the country, Wisconsin regulators are stepping in to clarify who can legally assess, prescribe, mix, and administer these treatments. In a new Joint Advisory Opinion issued June 25, 2025, six...
Jul 9, 2025 | Legal Compliance, Starting a Business, State-Specific Regulations
Good Faith Exams Are Still Required IV hydration therapy is medical care. That means every IV treatment must be: Based on a valid, individualized order from a Licensed Provider (LP) with prescriptive authority (such as a physician, PA, or NP); and Issued after a...
Jun 18, 2025 | Legal Compliance, News
Novo Nordisk, the pharmaceutical company behind Ozempic and Wegovy, is starting to lose its wave of lawsuits against compounders and related businesses offering semaglutide copycats. But here’s the reality that isn’t making headlines: even when Novo loses, the process...
Apr 29, 2025 | Legal Compliance, Risk Management
Regenerative medicine is revolutionizing healthcare, offering patients new hope through cutting-edge therapies like stem cell treatments, exosomes, platelet-rich plasma (PRP), and other tissue-based products. However, as innovation accelerates, so does the complexity...
